ArticleJournal, genetic engineering & biotechnology2025
Structure-based screening and molecular dynamics of phytophytochemicals against pseudomonas aeruginosa quorum sensing systems.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Effects of quercetin, baicalein, azithromycin, and their combination on biofilm formation, virulence factors and gene expression associated with Pseudomonas aeruginosa quorum sensing.Molecular biology reports · 2026Article
- In Silico Design and Characterization of the Essential Outer-Membrane Lipoprotein LolB-Derived Multi-Epitope Vaccine Candidate AgainstMethods and protocols · 2026Article
- Berberine Interferes with the Molecular Landscape of Biofilm-Driven Pathogenicity.Pathogens (Basel, Switzerland) · 2026Review
- Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis.Current research in structural biology · 2025Article
- Antibacterial and chemical profiling of Ulva intestinalis collected from Egypt.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas aeruginosa employs quorum sensing (QS) to regulate virulence and antibiotic resistance, making QS inhibition a promising anti-infective strategy. Here, we computationally evaluated three phytochemicals-baicalin, berberine, and cinnamaldehyde-as QS inhibitors targeting LasR, RhlR, and PqsR regulators. Molecular docking revealed berberine as the most potent PqsR binder (GScore: -6.801 kcal/mol), competitively displacing the native ligand HHQ, while baicalin showed broad-spectrum inhibition of PqsR/RhlR. Cinnamaldehyde exhibited moderate LasR antagonism. Molecular dynamics (100 ns) confirmed complex stability (RMSD < 2.5 Å) and identified key interactions: berberine formed a salt bridge with PqsR Asp264, while baicalin induced allosteric helix destabilization. Pharmacokinetic profiling showed that berberine is rapidly cleared (134.7 mL/min/kg) and poses a risk of drug-drug interactions due to CYP3A4 and CYP2D6 inhibition. This makes formulation strategies or analogue design more suitable than relying on metabolic inhibition. In contrast, baicalin has very poor absorption (bioavailability score: 0.11), indicating that nanoformulation is required to improve its uptake. Cinnamaldehyde demonstrated favourable drug-likeness but required structural optimization to mitigate aldehyde reactivity. This study provides in-silico mechanistic support for phytochemical-mediated QS inhibition in P. aeruginosa, with berberine emerging as a lead candidate for further development. Our integrative approach map water displacement hotspots in PqsR (GIST) and detect a baicalin-linked distal helix perturbation (DSSP) consistent with allostery, and bridges computational prediction and therapeutic design, offering new strategies to combat antimicrobial resistance through virulence attenuation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.